lercanidipine has been researched along with Essential Hypertension in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caimi, L; Cancarini, A; De Ciuceis, C; Duse, S; La Boria, E; Muiesan, ML; Paini, A; Ricotta, D; Rizzoni, D; Rosei, CA; Rosei, EA; Rossini, C; Ruggeri, G; Salvetti, M; Sarkar, A; Semeraro, F | 1 |
| Agabiti Rosei, E; De Ciuceis, C; Di Gregorio, J; Donini, C; Flati, V; La Boria, E; Pasini, E; Petroboni, B; Porteri, E; Rizzoni, D; Rossini, C; Rufo, A | 1 |
| Yang, Z | 1 |
| Ahn, JC; Ahn, T; Cha, DH; Cho, JH; Cho, SW; Choi, DJ; Hong Baek, S; Hong, S; Hong, TJ; Jeon, ES; Jeon, HK; Jeong, JO; Jeong, MH; John, SH; Juhn, JH; Kang, JH; Kim, BS; Kim, DW; Kim, JJ; Kim, MH; Kim, NH; Kim, SK; Kim, SW; Kim, SY; Kim, YN; Kwan, J; Lee, HY; Lee, NH; Lee, SH; Lee, SY; Lee, YJ; Na, SH; Oh, BH; Park, CG; Park, SH; Park, WJ; Rhee, MY; Ryu, JK; Shin, ES; Shin, JH; Uk Lee, S; Won, KH; Yoo, SY | 1 |
| Agabiti-Rosei, C; Agabiti-Rosei, E; Airò, P; Caimi, L; De Ciuceis, C; Ricotta, D; Rizzoni, D; Rossini, C; Ruggeri, G; Scarsi, M; Tincani, A | 1 |
| Rizzoni, D | 1 |
1 review(s) available for lercanidipine and Essential Hypertension
| Article | Year |
|---|---|
Fixed-dose lercanidipine and enalapril in field practice: a meta-analysis.
Topics: Antihypertensive Agents; Blood Pressure; Dihydropyridines; Drug Therapy, Combination; Enalapril; Essential Hypertension; Female; Humans; Hypertension; Male; Middle Aged; Outcome Assessment, Health Care | 2016 |
2 trial(s) available for lercanidipine and Essential Hypertension
| Article | Year |
|---|---|
Efficacy and safety evaluation of perindopril-lercanidipine combined therapy in patients with mild essential hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Dihydropyridines; Drug Therapy, Combination; Essential Hypertension; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome | 2015 |
Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Essential Hypertension; Female; Headache; Humans; Hypertension; Male; Middle Aged; Treatment Outcome; Valsartan; Young Adult | 2015 |
3 other study(ies) available for lercanidipine and Essential Hypertension
| Article | Year |
|---|---|
Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arterioles; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Diuretics; Drug Therapy, Combination; Enalapril; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Hypertension; Kidney; Laser-Doppler Flowmetry; Male; Middle Aged; Oxidative Stress; Ultrasonography | 2014 |
Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: a pilot study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Enalapril; Essential Hypertension; Female; Glucose Transporter Type 4; Humans; Hypertension; Insulin; Lymphocytes; Male; Middle Aged; Monocytes; Nifedipine; Pilot Projects; Signal Transduction; TOR Serine-Threonine Kinases | 2014 |
Effect of antihypertensive treatment with lercanidipine on endothelial progenitor cells and inflammation in patients with mild to moderate essential hypertension.
Topics: Antihypertensive Agents; Dihydropyridines; Endothelial Progenitor Cells; Essential Hypertension; Female; Humans; Hypertension; Inflammation; Male; Middle Aged; Risk Factors | 2016 |